Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham S, Llewellyn-Jones D, Perz J (1994) Changes in Australian women’s perception of the menopause and menopausal symptoms before and after the climacteric. Maturitas 20: 121–128
Adam K (1987) Total and percentage REM sleep correlate with body weight in 36 middle-aged people. Sleep 10: 69–77
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). American Psychiatric Association, Washington DC
Anderson E, Hamburger S, Liu JH, Rebar RW (1987) Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 156: 428–433
Angst J, Dobler-Mikola A (1984) Do the diagnostic criteria determine the sex ratio in depression? J Affect Disord 7: 189–198
Antonijevic IA, Stalla GK, Steiger A (2000) Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 182: 277–282
Archer JSM (1999) Relationship between estrogen, serotonin, and depression. Menopause 6: 71–78
Aro H (1994) Risk and protective factors in depression: a developmental perspective. Acta Psychiatr Scand (Suppl 377): 59–64
Arpels JC (1996) The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. J Reprod Med 41: 633–639
Asplund R, Åberg HE (1995) Body mass index and sleep in women aged 40 to 64 years. Maturitas 22: 1–8
Avis NE, Brambilla D, McKinlay SM, Vass K (1994) A longitudinal analysis if the association between menopause and depression: results from the Massachusetts Women’s Health Study. Annu Epidemiol 4: 214–220
Avis NE, McKinlay SM (1991) A longitudinal analysis of women’s attitudes toward the menopause: results from the Massachusetts Women’s Health Study. Maturitas 13: 65–79
Ballinger CB (1975) Psychiatric morbidity and the menopause: screening of a general population sample. BMJ 3: 344–346
Ballinger CB, Browning MCK, Smith AHW (1987) Hormone profiles and psychological symptoms in perimenopausal women. Maturitas 9: 235–251
Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perime-nopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84: 3896–3902
Barrett-Connor E, Von Muhlen D, Laughlin GA, Kripke A (1999) Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo Study. J Am Geriatr Soc 47: 685–691
Born L, Steiner M (1999) Irritability: the forgotten dimension of female-specific mood disorders. Arch Women Ment Health 2: 153–167
Breslau N, Schultz L, Peterson E (1995) Sex differences in depression: a role for preexisting anxiety. Psychiatry Res 58: 1–12
Bungay GT, Vessey MP, McPherson MK (1980) Study of symptoms in middle-life with special reference to the menopause. BMJ 2: 181–183
Busch CM, Zonderman AB, Costa PT Jr (1994) Menopausal transition and psychological distress in a nationally representative sample: is menopause associated with psychological distress ? J Aging Health 6: 209–228
Campbell S, Whitehead M (1977) Estrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 4: 31–47
Cawood EHH, Bancroft J (1996) Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 26: 925–936
Collins A, Landgren BM (1997) Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up of Swedish women. Maturitas 28: 1–9
Coope J (1981) Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 31: 134–140
Dennerstein L (1996) Well-being, symptoms and the menopausal transition. Maturitas 23: 147–157
Dennerstein L, Smith AM, Morse C, Burger H, Green A, Hopper J, Ryan M (1993) Menopausal symptoms in Australian women. BMJ 159: 232–236
Dennerstein L, Smith AMA, Morse C (1994) Psychological well-being, mid-life and the menopause. Maturitas 20: 1–11
Dören M (1999) Effects of SERMs on the uterus and menopausal symptoms. J Endocrinol Invest 22: 625–635
Gater RA, Dean C, Morris J (1989) The contribution of childbearing to the sex difference in first admission rates for affective psychosis. Psychol Med 19: 719–24
Greendale GA, Lee NP, Arriola ER (1999) The menopause. Lancet 353: 571–580
Halbreich U (1997) The role of estrogen in postmenopausal depression. Neurology 48(Suppl 7): S16–S20
Hallström T, Samuelsson S (1985) Mental health in the climacteric: the longitudinal study of women in Gothenburg. Acta Obstet Gynecol Scand 130: 13–18
Hamilton J, Halbreich U (1993) Special aspects of neuropsychiatric illness in women: Focus on depression. Ann Rev Med 44: 355–364
Harlow BL, Signorello LB (2000) Factors associated with early menopause. Maturitas 35: 3–9
Harris T, Surtees P, Bancroft J (1991) Is sex necessarily a risk factor for depression? Br J Psychiatry 158: 708–712
Hay AG, Bancroft J, Johnstone EC (1994) Affective symptoms on women attending a menopause clinic. Br J Psychiatr 164: 513–516
Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Shumaker SA, Brzyski RG, La Croix AZ, Granek IA, Valanis BG, for the Women’s Health Initiative Investigators (2003) Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348: 1839–1854
Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W (1999) A new ‘Aging Males’ Symptom Rating Scale. The Aging Male 2: 105–114
Holte A (1992) Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 14: 127–141
Holte A, Mikkelsen A (1982) Menstrual coping style, social background and climacteric symptoms. Psychiatr Soc Sci 2: 41–45
Huerta R, Mena A, Malacara JM, Diaz de Leon J (1995) Symptoms at perimenopausal period: its association with attitudes toward sexuality, life-style, family function, and FSH levels. Psychoneuroendocrinol 20: 135–148
Hunter M (1990) Somatic experience of the menopause: a prospective study. Psychosom Med 52: 357–367
Hunter M (1992) The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 14: 117–126
Huppert FA, van Niekerk JK, Herbert J (2000) Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being (cochrane review). In: The Cochrane Library, issue 1, Oxford: update software CD 000304
Jorm AF (1987) Sex and age differences in depression: a quantitative synthesis of published research. Austral N Zeal J Psychiatry 21: 46–53
Kaufert P, Boggs PP, Ettinger B, Fugate Woods N, Utian WH (1998) Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 5: 197–202
Kaufert PA, Gilbert P, Tate R (1992) The Manitoba project: a reexamination of the link between menopause and depression. Maturitas 14: 143–155
Kessler R, McGonagle R, Swartz M, Blazer DG, Nelson CB (1993) Sex and depression in the National Comorbidity Survey: lifetime prevalence, chronicity, and recurrence. J Affect Disord 29: 85–96
Khastgir G, Studd J (1998) Hysterectomy, ovarian failure, and depression. Menopause 5: 113–122
Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB (1997) Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychneuroendocrinol 22: 549–558
Kuh DL, Wadsworth M, Hardy R (1997) Women’s health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 104: 923–933
Lacroix C, Fiet J, Benais JP, Gueux B, Bonete R, Villette JM, Gourmel B, Dreux C (1987) Simultaneous radioimmunoassays of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J Steroid Biochem 28: 317–325
Lalive d'Epinay CJ (1985) Depressed elderly women in Switzerland: an example of testing and of generating theories. Gerontologist 25: 597–604
Ledésert B, Ringa V, Bréat G (1995) Menopause and perceived health status among the women of the French GAZEL cohort. Maturitas 20: 113–120
Leon AC, Klerman GL, Wickramaratne P (1993) Continuing female predominance in depressive illness. Am J Public Health 83: 754–757
Li C, Samsioe G, Lidfeldt J, Nerbrand C, Agardh CD (2000) Important factors for use of hormone replacement therapy. A population-based study of Swedish women. The Women’s Health in Lund Area (WHILA) Study. Menopause 7: 273–281
Makhlouf Obermeyer C (2000) Menopause across cultures: a review of the evidence. Menopause 7: 184–192
Manber R, Armitage R (1999) Sex, steroids, and sleep: a review. Sleep 22: 540–555
Matthews KA (1992) Myths and realities of the menopause. Psychosom Med 54: 1–9
Matthews KA, Kuller LH, Wing RR, Meilahn EN (1994) Biobehavioral aspects of menopause: lessons from the healthy women study. Exp Gerontol 29: 337–342
McKinlay JB, McKinlay SM, Brambilla D (1987) The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav 28: 345–363
Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, Studd JW (1987) Effect of oestrogen and testosterone implants on psychological disorders on the climacteric. Lancet: 297–299
Morales A, Nolan J, Nelson J, Yen S (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endcorinol Metab 78: 1360–1367
Morse CA, Smith A, Dennerstein L, Green A, Hopper J, Burger H (1994) The treatment-seeking woman at menopause. Maturitas 18: 161–173
Neri I, Demyttenaere K, Facchinetti F (1997) Coping style and climacteric symptoms in a clinical sample of postmenopausal women. J Psychosom Obstet Gynecol 18: 229–233
Neugarten BL, Kraines RJ (1965) Menopausal symptoms of women of various ages. Psychosom Med 27: 266–273
Nicol-Smith L (1996) Causality, menopause, and depression: a critical review of the literature. Br Med J 313: 1229–1232
Notelovitz M (1999) Discovery and identification of estrogen. Menopause 6: 2–3
Owens JF, Matthews KA (1998) Sleep disturbances in healthy middle-aged women. Maturitas 30: 41–50
Parry B (1989) Reproductive factors affecting the course of affective illness in women. Psychiatr Clin North Am 12: 207–220
Pearce J, Hawton K, Blake F (1995) Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psychiatry 167: 163–173
Pearlstein T, Rosen K, Stone AB (1997) Mood disorders and menopause. Endocrinol Metab Clin North Am 26: 279–294
Polit DF, LaRocco SA (1982) Social and psychological correlates of menopausal symptoms. Psychosom Med 42: 335–345
Polo-Kantola P, Erkkola R, Helenius H, Irjala K, Polo O (1998) When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 178: 1002–1009
Polo-Kantola P, Erkkola R, Irjala K, Pillinen S, Virtanen I, Polo O (1999) Effect of short-term transdermal estrogen replacement therapy on sleep: a randomised, double-blind crossover trial in postmenopausal women. Fertil Steril 71: 873–880
Porter M, Penney GC, Russell D, Russell E, Templeton A (1996) A population based survey of women’s experience of menopause. Br J Obstet Gynaecol 103: 1025–1028
Purdie DW, Empson JA, Crichton C, Macdonald L (1995) Hormone replacement therapy, sleep quality and psychological wellbeing. Br J Obstet Gynaecol 102: 735–739
Rubinow DR, Schmidt PJ (1995) The neuroendocrinology of menstrual cycle mood disorders. Ann N Y Acad Sci 771: 648–659
Saletu B, Brandstaetter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, Heytmanek G, Huber J, Grunberger J, Linzmayer L (1995) Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacol 122: 321–329
Schiff I, Regestein Q, Tuchinsky D, Ryan KJ (1979) Effects of estrogens on sleep and psychological state of hypogonadal women. J Am Med Assoc 245: 1741–1744
Schneider L, Small G, Hamilton S, Bystritsky A, Nemeroff C, Myers B (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial: fluoxetine collaborative study group. Am J Psychiatry 5: 97–106
Schultz-Zehden B (1998) Frauengesundheit in und nach den Wechseljahren. Die 1000-Frauen-Studie. Kempkes, Gladenbach
Sherwin B (1991) Estrogen and refractory depression. In: Amsterdam JD (ed) Advances in neuropsychiatry and psychopharmacology, vol 2: Refractory depression. Raven Press, New York, 209–218
Silverstein B, Perlick G (1991) Gender differences in depression: historical changes. Acta Psychiatr Scand 84: 327–331
Simon G, Ormel J, von Korff M, Barlow M (1995) Health Care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 152: 352–357
Snow V, Lascher S, Mottur-Pilson C (2000) Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians — American Society of Internal Medicine. Ann Intern Med 132: 738–742
Stahl SM (1998) Basic neuropharmacology of antidepressants, part 2: estrogen as an adjunct to antidepressant treatment. J Clin Psychiatry 59(Suppl 4): 15–24
Stearns V, Beebe KL, Iyenger M, Dube E (2003) Paroxetine controlled release in the treatment of menopausal lot flush. A randomized controlled trial. J Am Med Assoc 289: 2827–2834
Stewart DE, Boydell K (1993) Psychologic distress during menopause. Associations across the reproductive life cycle. Int J Psychiatr Med 23: 157–162
Stewart DE, Boydell K, Derzko C, Marshall V (1992) Psychologic distress during the menopausal years in women attending a menopause clinic. Int J Psychiatr Med 22: 213–220
Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR (1999) Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women. Gynecol Endocrinol 13: 15–25
Stommel M, Given BA, Given CW, Kalaian HA, Schulz R, McCorkle R(1993) Gender bias in the measurement properties of the Center for Epidemiologic Studies Depression Scale (CES-D). Psychiatry Res 49: 239–250
Stoppe G, Sandholzer H, Huppertz C, Duwe H, Staedt J (1999) Gender differences in the recognition of depression in old age. Maturitas 32: 205–212
Stoppe G, von Sydow K, Krasney N (2000) Die Psyche in der Peri-und Postmenopause. Reproduktionsmedizin 16: 253–260
Thomson J, Oswald I (1977) Effect of estrogen on sleep, mood and anxiety of menopausal women. Br Med J 2: 1317–1319
Topo P, Koster A., Holte A, Collins A, Landgren BM, Hemminmi E et al. (1995) Trends in the use of climacteric and postclimacteric hormones in nordic countries. Maturitas 22: 89–95
Utian WH (1972) The mental tonic effect of oestrogens administered to oophorectomized females. S Afr Med J 46: 1979–1082
van Duijn CM (1997) Menopause and the brain. J Psychosom Obstet Gynaecol 18: 121–125
van Hall EV, Verdel M, van der Velden J (1994) "Perimenopausal" complaints in women and men: a comparative study. J Women’s Health 3: 45–55
von Sydow K, Reimer C (1995) Psychosomatik der Menopause: Literaturübersicht 19882–19992. Psychother Psychosom Med Psychol 45: 225–236
Weissman M, Leaf PJ, Tischler GL, Blazer DG, Kerno M, Bruce ML, Florio LP (1988) Affective disorders in five United States communities. Psychol Med 18:141–153
Wells JE, Bushnell JA, Hornblow AR, Joyce PR, Oakley-Browne MA (1989) Christchurch psychiatric epidemiology study. Part I. Methodology and lifetime prevalence for specific psychiatric disorders. Austral N Zeal J Psychiatry 23: 315–326
WHO — World Health Organization (1991) Mental and behavioral disorders (including disorders of psychological development). Clinical descriptions and diagnostic guidelines. 10th revision of the International Classification of diseases, Chap V (F), Geneva
Wiklund I, Berg G, Hammar M, Karlberg-J, Lindgren R, Sandin K (1992) Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas 14: 225–236
Wilbur JE, Dan A, Hedricks C, Holm K (1990) The relationship among menopausal status, menopausal symptoms, and physical activity in midlife women. Fam Community Health 13: 67–78
Wilhelm K, Parker G (1989) Is sex necessarily a risk factor for depression? Psychol Med 19: 401–413
Wilhelm K, Parker G (1994) Sex differences in lifetime depression rates: fact or artefact? Psychol Med 24: 97–111
Williams JB, Spitzer RL, Linzer M et al. (1995) Gender differences in depression in primary care. Am J Obstet Gynecol 173: 654–659
Wolf OT, Kirschbaum C (1999) Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Rev 30: 264–288
Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke K-M, Kirschbaum C (1997) Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly man and women. J Clin Endocrinol Metab 82: 2363–2367
Young MA, Fogg LF, Scheftner WA, Keller MB, Fawcett JA (1990) Sex differences in the lifetime prevalence of depression: does varying the diagnostic criteria reduce the female/male ratio? J Affect Disord 18: 187–192
Zweifel JE, O'Brien WH (1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22: 189–212 (see also: The Cochrane Library 2000; 1: 1–5)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag/Wien
About this chapter
Cite this chapter
Stoppe, G., Dören, M. (2005). Estrogen Therapy in Perimenopausal Affective Disorders. In: Bergemann, N., Riecher-Rössler, A. (eds) Estrogen Effects in Psychiatric Disorders. Springer, Vienna. https://doi.org/10.1007/3-211-27063-9_10
Download citation
DOI: https://doi.org/10.1007/3-211-27063-9_10
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-40485-0
Online ISBN: 978-3-211-27063-9
eBook Packages: MedicineMedicine (R0)